HYBRID MRNA TECHNOLOGY Trademark

Trademark Overview


On Friday, August 26, 2016, a trademark application was filed for HYBRID MRNA TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the HYBRID MRNA TECHNOLOGY trademark a serial number of 87152206. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 6, 2018. This trademark is owned by PhaseRx, Inc.. The HYBRID MRNA TECHNOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, a drug delivery system composed of polymers and lipid nanoparticles delivered as integral components of drugs used for the delivery of macromolecules to human tissue

Medical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics for others; product research and development for others in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics
hybrid mrna technology

General Information


Serial Number87152206
Word MarkHYBRID MRNA TECHNOLOGY
Filing DateFriday, August 26, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 6, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"MRNA OR TECHNOLOGY"
Goods and ServicesPharmaceutical preparations, namely, a drug delivery system composed of polymers and lipid nanoparticles delivered as integral components of drugs used for the delivery of macromolecules to human tissue
Goods and ServicesMedical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics for others; product research and development for others in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 1, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhaseRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, February 6, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 11, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 11, 2017FINAL REFUSAL E-MAILED
Tuesday, July 11, 2017FINAL REFUSAL WRITTEN
Friday, June 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 11, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 11, 2016NON-FINAL ACTION E-MAILED
Sunday, December 11, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2016ASSIGNED TO EXAMINER
Thursday, September 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 30, 2016NEW APPLICATION ENTERED IN TRAM